Citations

Clear

3030 citation(s) found for "Susan, M".

LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes
Llano, Manuel , Vanegas, Maria, Fregoso, Oliver I. , Saenz, Dyana T. , Chung, Susan, Peretz, Mary, Poeschla, Eric M.

Mayo Clinic

Journal of Virology | August 13, 2004 | Volume: 78 | Issue: 17 | Pages: 9524-9537

10.1128/jvi.78.17.9524-9537.2004 | PMID 15308744 Get It

ABSTRACT Human immunodeficiency virus type 1 (HIV-1), feline immunodeficiency virus (FIV), and Moloney murine leukemia virus (MoMLV) integrases were stably expressed to determine their intracellular trafficking. Each lentiviral integrase localized to cell nuclei in close association with chromatin while the murine oncoretroviral integrase was cytoplasmic. Fusions of pyruvate kinase to the lentiviral integrases did not reveal transferable nuclear localization signals. The intracellular trafficking of each was determined instead by the transcriptional coactivator LEDGF/p75, which was required for nuclear localization. Stable small interfering RNA expression eliminated detectable LEDGF/p75 expression and caused dramatic, stable redistribution of each lentiviral integrase from nucleus to cytoplasm while the distribution of MoMLV integrase was unaffected. In addition, endogenous LEDGF/p75 coimmunoprecipitated specifically with each lentiviral integrase. In vitro integration assays with preintegration complexes (PICs) showed that endogenous LEDGF/p75 is a component of functional HIV-1 and FIV PICs. However, HIV-1 and FIV infection and replication in LEDGF/p75-deficient cells was equivalent to that in control cells, whether cells were dividing or growth arrested. Two-long terminal repeat circle accumulation in nondividing cell nuclei was also equivalent to that of LEDGF/p75 wild-type cells. Virions produced in LEDGF/p75-deficient cells had normal infectivity. We conclude that LEDGF/p75 fully accounts for cellular trafficking of diverse lentiviral, but not oncoretroviral, integrases and is the main lentiviral integrase-to-chromatin tethering factor. While lentiviral PIC nuclear import is unaffected by LEDGF/p75 knockdown, this protein is a component of functional lentiviral PICs. A role in HIV-1 integration site distribution merits investigation.
Malignant Pineal Parenchymal Tumors in Adult Patients: Patterns of Care and Prognostic Factors
Lutterbach, Johannes, Fauchon, F., Schild, Steven E. , Chang, Susan M. , Pagenstecher, Axel , Volk, Benedikt, Ostertag, Christoph B., Momm, Felix , Jouvet, Anne, Schild, Steven

Mayo Clinic

Neurosurgery | July 29, 2004 | Volume: 51 | Issue: 1 | Pages: 44-56

10.1097/00006123-200207000-00006 | PMID 12182434 Get It

Abstract OBJECTIVE The aim of our study was to analyze patterns of care and to identify prognostic factors in patients at least 18 years of age who received radiotherapy for malignant pineal parenchymal tumors. METHODS In a multicenter, retrospective study, we analyzed data for 37 previously published cases and 64 patients treated at the participating institutions. RESULTS A total of 56 patients received postoperative radiotherapy, and 45 patients received primary radiotherapy. Chemotherapy was administered to 34 patients. The median follow-up period was 38 months, and median overall survival was 100 months. The variables that significantly influenced overall survival were the extent of disease (localized versus disseminated; P = 0.0002), differentiation (pineal parenchymal tumor of intermediate differentiation versus pineoblastoma; P = 0.001), and residual disease (≥50% versus <50% reduction in size; P < 0.0001). In a multivariate analysis, the parameters turned out to be independent risk factors. The median survival in patients with local or spinal failure was 15 months. Local control was better in older patients (≥32 yr versus <32 yr; P = 0.02). Spinal control was more successful in patients with pineal parenchymal tumors of intermediate differentiation than it was in patients with pineoblastomas (P = 0.03). Nine of 45 treatment failures occurred later than 5 years after treatment. CONCLUSION Stage, histological characteristics, and response are independent risk factors in adults with malignant pineal parenchymal tumors. Late relapses are common.
Idiopathic Interstitial Pneumonia
Flaherty, Kevin R. , King, Talmadge E. , Raghu, Ganesh , Lynch, Joseph P., Colby, Thomas V. , Gross, Barry H., Kazerooni, Ella A. , Toews, Galen B., Long, Qi , Murray, Susan , Lama, Vibha N. , Gay, Steven E., Long, Qi , Travis, William D. , Martínez, Fernando J. , Long, Qi

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | July 15, 2004 | Volume: 170 | Issue: 8 | Pages: 904-910

10.1164/rccm.200402-147oc | PMID 15256390 Get It

Abstract Current guidelines recommend that the clinician, radiologist, and pathologist work together to establish a diagnosis of idiopathic interstitial pneumonia. Three clinicians, two radiologists, and two pathologists reviewed 58 consecutive cases of suspected idiopathic interstitial pneumonia. Each participant was provided information in a sequential manner and was asked to record their diagnostic impression and level of confidence at each step. Interobserver agreement improved from the beginning to the end of the review. After the presentation of histopathologic information, radiologists changed their diagnostic impression more often than did clinicians. In general, as more information was provided the confidence level for a given diagnosis improved, and the diagnoses rendered with a high level of confidence were more likely congruent with the final pathologic consensus diagnosis. The final consensus pathologist diagnosis was idiopathic pulmonary fibrosis in 30 cases. Clinicians identified 75% and radiologists identified 48% of these cases before presentation of the histopathologic information. Histopathologic information has the greatest impact on the final diagnosis, especially when the initial clinical/radiographic diagnosis is not idiopathic pulmonary fibrosis. We conclude that dynamic interactions between clinicians, radiologists, and pathologists improve interobserver agreement and diagnostic confidence.
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes
Quella, Susan K., Loprinzi, Charles L. , Sloan, Jeff A. , Vaught, Nancy L., DeKrey, Wanda L., Fischer, Tammy, Finck, Gwen, Pierson, Nancy, Pisansky, Thomas M.

Mayo Clinic

Cancer | July 1, 2004 | Volume: 82 | Issue: 9 | Pages: 1784-1788

10.1002/(sici)1097-0142(19980501)82:9<1789::aid-cncr27>3.0.co;2-# Get It

Assessing Sexual Behavior in High-Risk Adolescents with the Adolescent Clinical Sexual Behavior Inventory (ACSBI)
Friedrich, William N., Lysne, Marit, Sim, Leslie , Shamos, Susan

Mayo Clinic

Child Maltreatment | June 22, 2004 | Volume: 9 | Issue: 3 | Pages: 239-250

10.1177/1077559504266907 | PMID 15245677 Get It

This study examined the reliability and validity of the Adolescent Clinical Sexual Behavior Inventory (ACSBI), a new 45-item measure, designed to elicit parent-and self-report regarding a range of sexual behaviors in high-risk adolescents. Using this measure, this study also investigated predictors of adolescent sexual behavior. Participants were 174 adolescents and their parents consecutively admitted to one of three clinical settings (i.e., inpatient treatment, partial hospital program, and outpatient clinic). Parent-and self-reports of adolescent sexual behavior were moderately correlated, and there was a strong relationship between high-risk sexual behavior and adolescent emotional and behavioral problems, as well as sexual concerns, distress, and preoccupation. In addition to sexual abuse, physical abuse, life stress, and impaired family relationships also significantly predicted sexual behavior in adolescents.
Reconstruction of in vivo time-evolving neuroendocrine dose–response properties unveils admixed deterministic and stochastic elements
Keenan, Daniel M., Irvine, C. H. G., Clarke, Iain J. , Scott, Christopher , Turner, Anne I. , Tilbrook, A.J. , Canny, Benedict J., Veldhuis, Johannes D. , Alexander, Susan

Mayo Clinic

Proceedings of the National Academy of Sciences | April 16, 2004 | Volume: 101 | Issue: 17 | Pages: 6740-6745

10.1073/pnas.0300619101 | PMID 15090645 Get It

Homeostasis in the intact organism is achieved implicitly by repeated incremental feedback (inhibitory) and feedforward (stimulatory) adjustments enforced via intermittent signal exchange. In separated systems, neurohormone signals act deterministically on target cells via quantifiable effector-response functions. On the other hand, in vivo interglandular signaling dynamics have not been estimable to date. Indeed, experimentally isolating components of an interactive network definitionally disrupts time-sensitive linkages. We implement and validate analytical reconstruction of endogenous effector-response properties via a composite model comprising ( i ) a deterministic basic feedback and feedforward ensemble structure; ( ii ) judicious statistical allowance for possible stochastic variability in individual biologically interpretable dose–response properties; and ( iii ) the sole data requirement of serially observed concentrations of a paired signal (input) and response (output). Application of this analytical strategy to a prototypical neuroendocrine axis in the conscious uninjected horse, sheep, and human ( i ) illustrates probabilistic estimation of endogenous effector dose–response properties; and ( ii ) unmasks statistically vivid (2- to 5-fold) random fluctuations in inferred target-gland responsivity within any given pulse train. In conclusion, balanced mathematical formalism allows one to ( i ) reconstruct deterministic properties of interglandular signaling in the intact mammal and ( ii ) quantify apparent signal-response variability over short time scales in vivo . The present proof-of-principle experiments introduce a previously undescribed means to estimate time-evolving signal-response relationships without isotope infusion or pathway disruption.
Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors
Trepanier, Angela , Ahrens, Mary, McKinnon, Wendy, Peters, June A. , Stopfer, Jill E. , Grumet, Sherry, Manley, Susan, Culver, Julie O. , Acton, Ronald T. , Larsen‐Haidle, Joy, Correia, Lori Ann, Bennett, Robin L. , Pettersen, B., Ferlita, Terri Diamond, Costalas, Josephine Wagner, Hunt, Katherine S., Donlon, Susan S., Skrzynia, Cécile, Farrell, Carolyn, Callif‐Daley, Faith, Vockley, Catherine Walsh

Mayo Clinic

Journal of Genetic Counseling | March 9, 2004 | Volume: 13 | Issue: 2 | Pages: 83-114

10.1023/b:jogc.0000018821.48330.77 | PMID 15604628 Get It

AbstractThese cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of identifying at‐risk individuals through cancer risk assessment with or without genetic testing. They were developed by members of the Practice Issues Subcommittee of the National Society of Genetic Counselors Cancer Genetic Counseling Special Interest Group. The information contained in this document is derived from extensivereview of the current literature on cancer genetic risk assessment and counseling as well as the personal expertise of genetic counselors specializing in cancer genetics. The recommendations are intended to provid information about the process of genetic counseling and risk assessment for hereditary cancer disorders rather than specific information about individual syndromes. Key components include the intake (medical and family histories), psychosocial assessment (assessment of risk perception), cancer risk assessment (determination and communication of risk), molecular testing for hereditary cancer syndromes (regulations, informed consent, and counseling process), and follow‐up considerations. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. These recommendations do not displace a health care provider's professional judgment based on the clinical circumstances of a client.
Measurement of Plasma Free Metanephrine and Normetanephrine by Liquid Chromatography–Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma
Lagerstedt, Susan A., O’Kane, Dennis J., Singh, Ravinder J.

Mayo Clinic

Clinical Chemistry | February 23, 2004 | Volume: 50 | Issue: 3 | Pages: 603-611

10.1373/clinchem.2003.024703 | PMID 14726465 Get It

AbstractBackground: Quantification of plasma free metanephrines is usually accomplished by HPLC with electrochemical detection, but sample preparation is labor-intensive and time-consuming, run times are long, and interfering substances sometimes obscure the relevant peaks. The aim of this study was to develop a sensitive and specific LC-MS/MS method for plasma free metanephrines.Methods: After solid-phase extraction, chromatographic separation of normetanephrine (NMN) and metanephrine (MN) was accomplished by use of a cyano analytical column. NMN, MN, d3-NMN, and d3-MN positive ions were detected in the multiple-reaction monitoring mode using the specific transitions m/z 166→134, 180→148, 169→137, and 183→151, respectively, with an atmospheric pressure chemical ionization source.Results: Multiple calibration curves exhibited consistent linearity and reproducibility. Interassay imprecision values (CV; n = 20) for NMN at 0.64, 1.9, and 2.7 nmol/L were 6.6%, 7.8%, and 13%, respectively. Interassay CV for MN at 0.60, 1.2, and 2.1 nmol/L (n = 20) were 9.2%, 6.8%, and 9.8%, respectively. The mean recoveries of NMN and MN relative to the internal standard were 100% and 96%, respectively. The assays were linear between 0.20 and 10.0 nmol/L. Deming regression of HPLC and LC-MS/MS results yielded slopes of 0.93 (95% confidence interval, 0.89–0.98) and 0.89 (0.85–0.93) and y-intercepts of −0.16 and 0.03 nmol/L for NMN (n = 132) and MN (n = 92), respectively.Conclusions: This novel LC-MS/MS approach provides a precise, rapid, and specific alternative method to HPLC for the quantification of the low nanomolar concentrations of free metanephrines in plasma.
Management of Urinary Incontinence and Nocturnal Enuresis in Attention-Deficit Hyperactivity Disorder
Crimmins, Christopher R., Rathbun, Susan, Husmann, Douglas A.

Mayo Clinic

Journal of Urology | November 18, 2003 | Volume: 170 | Issue: 4 Part 1 | Pages: 1347-1350

10.1097/01.ju.0000084669.59166.16 | PMID 14501767 Get It

Myocardial Contractile Reserve by Dobutamine Stress Echocardiography Predicts Improvement in Ejection Fraction With β-Blockade in Patients With Heart Failure
Eichhorn, Eric J., Grayburn, Paul , Mayer, Susan A., Sutton, Martin St. John, Appleton, Christopher, Plehn, Jonathan F. , Oh, Jae K. , Greenberg, Barry , DeMaria, Anthony N. , Frantz, Robert P. , Krause‐Steinrauf, Heidi , Frantz, Robert P

Mayo Clinic

Circulation | November 4, 2003 | Volume: 108 | Issue: 19 | Pages: 2336-2341

10.1161/01.cir.0000097111.00170.7b | PMID 14597587 Get It

Background— β-Blockers improve survival and reduce hospitalization in chronic heart failure (CHF) by biologically improving left ventricular ejection fraction (LVEF). However, a good predictor of improvement with this therapy has not been identified. This substudy of BEST examined whether myocardial contractile reserve, as determined by dobutamine stress echocardiography, predicts improvement in LVEF. Methods and Results— Seventy-nine patients with class III/IV CHF underwent dobutamine stress echocardiography before treatment with bucindolol (n=41) or placebo (n=38). Regional wall motion score index (WMSI) was calculated as the sum of the scores in each segment divided by the total number of segments visualized. WMSI was compared with change in LVEF after 3 months of therapy as determined by gated radionuclide scan. Change in WMSI correlated inversely with change in LVEF after 3 months of bucindolol ( r =−0.72, P <0.0001) and was the most significant multivariate predictor of change in LVEF ( P =0.0002). Patients with contractile reserve had demographics similar to those of patients without contractile reserve, including RVEF, LVEF, systolic blood pressure, and CHF duration. However, patients without contractile reserve had higher baseline plasma norepinephrine levels (687±333 versus 420±246 pg/mL, P <0.05) and greater decrease in plasma norepinephrine in response to bucindolol (−249±171 versus −35±277 pg/mL, P <0.05). Conclusions— This study suggests a direct relationship between contractile reserve and improvement in LVEF with β-blocker therapy in patients with advanced CHF. Patients without contractile reserve have higher resting adrenergic drive, as reflected by plasma norepinephrine, and may experience greater sympatholytic effects from bucindolol.